Article thumbnail

Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study

By M. Schuur, P. Henneman, J. C. van Swieten, M. C. Zillikens, I. de Koning, A. C. J. W. Janssens, J. C. M. Witteman, Y. S. Aulchenko, R. R. Frants, B. A. Oostra, K. Willems van Dijk and C. M. van Duijn

Abstract

While type 2 diabetes is well-known to be associated with poorer cognitive performance, few studies have reported on the association of metabolic syndrome (MetS) and contributing factors, such as insulin-resistance (HOMA-IR), low adiponectin-, and high C-reactive protein (CRP)- levels. We studied whether these factors are related to cognitive function and which of the MetS components are independently associated. The study was embedded in an ongoing family-based cohort study in a Dutch population. All participants underwent physical examinations, biomedical measurements, and neuropsychological testing. Linear regression models were used to determine the association between MetS, HOMA-IR, adiponectin levels, CRP, and cognitive test scores. Cross-sectional analyses were performed in 1,898 subjects (mean age 48 years, 43% men). People with MetS had significantly higher HOMA-IR scores, lower adiponectin levels, and higher CRP levels. MetS and high HOMA-IR were associated with poorer executive function in women (P = 0.03 and P = 0.009). MetS and HOMA-IR are associated with poorer executive function in women

Topics: Neuro-Epidemiology
Publisher: Springer Netherlands
OAI identifier: oai:pubmedcentral.nih.gov:2921069
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). Adiponectin andthe metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol.
  2. (2008). Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol.
  3. (2004). Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care.
  4. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents.
  5. (2007). Adiponectin stimulates AMPactivated protein kinase in the hypothalamus and increases food intake. Cell Metab.
  6. (2004). Adipose tissue and adipokines: for better or worse. Diabetes Metab.
  7. An approach for cutting large and complex pedigrees for linkage analysis.
  8. (2009). Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis.
  9. Aulchenko YS. Heritability of fasting glucose levels in a young genetically isolated population.
  10. (2005). Aulchenko YS. The effect of genetic drift in a young genetically isolated population. Ann Hum Genet.
  11. (2005). Cerebral small-vessel disease and decline in information processing speed, executive function
  12. (2007). Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF study. Neurobiol Aging.
  13. (2009). Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol.
  14. Cognitive associations of subcortical white matter lesions in older people.
  15. (2008). Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord.
  16. (2007). Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol Aging.
  17. Diabetes mellitus and the risk of dementia: the Rotterdam study.
  18. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement.
  19. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
  20. (2002). Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res.
  21. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  22. (2006). Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care.
  23. hyperinsulinemia, diabetes and Alzheimer’s disease an epidemiological perspective.
  24. Inflammatory markers of coronary risk.
  25. Insulin resistance in cognitive impairment: the InCHIANTI study.
  26. (2005). Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging.
  27. Linkage disequilibrium in young genetically isolated Dutch population.
  28. Mental slowness and executive dysfunctions in patients with metabolic syndrome.
  29. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento area Latino study of aging study.
  30. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord. 2007;21: 167–71. Insulin-resistance and metabolic syndrome are related to executive function 567
  31. (2007). Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord.
  32. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people.
  33. Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study.
  34. (2000). Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory.
  35. Multipoint quantitative-trait linkage analysis in general pedigrees.
  36. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
  37. (2007). Penninx BW. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care.
  38. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey.
  39. (2008). Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care.
  40. (1978). Stroop kleur-woord test: Dutch manual. Lisse, The Netherlands: Swets and Zeitlinger BV;
  41. (2008). The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging
  42. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study.
  43. (2005). The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care.
  44. (2009). The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol.
  45. The metabolic syndrome—a new worldwide definition.
  46. the metabolic syndrome, and risk of coronary heart disease in women and men.
  47. The metabolic syndrome, inflammation, and risk of cognitive decline.
  48. The relation of the trail making test to organic brain damage.
  49. (2004). The SSG. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J.
  50. (2009). Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta.